• There are no suggestions because the search field is empty.

What to focus on when validating a computer system? (3)

Author Avatar
QbD Group
Software Solutions & Services
Pharma & Biotech
Without question, the impact of GxP processes such as product quality and patient health are at the top of the list when it comes to assessing the risks of a computer system. These are crucial in deciding whether to validate a computerized system. Therefore, experience and end user knowledge are of great value when weighting the impacts.
What to focus on when validating a computer system? (3) | QbD Group
3:06

 

GxP Processes

 

At first glance, business processes are not important from a regulatory point of view. However, it is necessary to assess them if the company wishes to continue to generate value from the processes. A strategy, for example, in which the costs do not cover the maintenance of the system or the required validation, may result in significant risks that jeopardise the future of the company.

Another example: a distributor of medicines does not manufacture the products and does not perform analysis to determine the purity and identity of the products. The main activity of the distributor is to store and to deliver. This system does not directly affect patient safety. However, it may affect product quality if the distribution is not performed according to the manufacturer’s instructions. As a consequence, patient safety may also be at risk. This could result in a violation of GxP and business requirements. Many (in)direct factors can impact the quality of a product and thus patient health.

QbD product quality main pillars

The internal policy has a great influence on the product quality via the quality management system (QMS). The entire staff should be aware of or be involved in the QMS. The more impact on the product quality the more they should be involved. Think of IT, management, human resources, QA department, production, suppliers, distributors, etc. Not applying GxP practices can result in a loss of credibility towards customers, demands, plant closure, fines, or worse: in a negative impact on patient health.

When a company is not in control of the training and qualification of personnel, this means unqualified personnel is operating the system. This increases the uncertainty of the system and thus leads to greater risks.

When a company lacks controls and procedures for the use, archiving, backup, restoring, transmission, and modification of data, it is likely that the process is missing data integrity. For instance, an employee is faced with an error in a system while processing a medicine. The employee does not follow the standard procedure and asks an IT employee to resolve the problem quickly. The data is modified on request without adhering to the procedures. The result? The risk of lack of data integrity is significant.

In conclusion, validating a computer system involves many layers of processes. It is inseparably intertwined with the QMS. Data is a big deal.

You can read more about data integrity in a previous blogpost and we’ll handle the topic again in one of our next blogs.

 

How can QbD Group help you?

 

QbD Group has different experts in computer system validation in its team. If you have any questions concerning the topics mentioned above, don’t hesitate to contact us!

 

Stay ahead in life sciences

Keeping up with the fast-paced life sciences industry doesn’t have to be overwhelming.

Our newsletter delivers the latest insights, industry updates, and expert content directly to your inbox, helping you stay informed and make smarter decisions.

Circles-banner-short

Discover more expert content

preview_image
Webinar

From Requirements to Code: a unified MDSW development cycle that covers all requirements

Watch our webinar on demand to master medical device software development. Learn about IEC standards, cybersecurity, AI integration, and FDA expectations.
preview_image
Whitepaper

Mobile health on the rise: exploring the regulatory landscape for reimbursement

This whitepaper will help you navigate the maze of the DTx regulatory environment, highlighting several important countries and regulations.
preview_image
Whitepaper

GAMP 5 Software Validation Approach for GMP, GCP and GLP regulations

Learn how to comply with GMP, GCP, and GLP regulations using the GAMP 5 Software Validation Approach. Download the whitepaper for more insights.
preview_image
Webinar

Getting Started: Overcoming Initial Obstacles in Medical Device Software Development

Watch our webinar on demand and learn about regulatory obstacles, MDR, AI Act, and best practices for medical device software development and market entry.
preview_image
Blog

What Makes Usability Testing Crucial for Near-Patient and Self-Testing Devices under IVDR?

It shouldn’t be a surprise that today, “Near-Patient Testing (NPT)” and...
preview_image
Blog

When does Annex XIV apply in Performance Studies, and what key documentation is needed for compliance?

In the European regulatory landscape, conducting performance studies for in...
preview_image
Blog

How to define your Clinical Performance Strategy?

1. Start with a clear intended purpose A strong clinical...
preview_image
Blog

The Holy Grail: Achieving Inspection Readiness

In a previous blog post, we talked about the various activities...